• English
  • Sign In
  • Contact Us
×
Catalog Products » Recombinant Proteins » Virus Antigens » SARS-CoV-2 Nucleocapsid protein

SARS-CoV-2 Nucleocapsid protein

SARS-CoV-2 Nucleocapsid Protein

Immobilized SARS-CoV-2 Nucleocapsid Antibody (HC2003), Human Chimeric (Cat. No. A02039) at 2 μg/mL can bind SARS-CoV-2 Nucleocapsid protein (Cat. No. Z03488) with a serial dilution.
SARS-CoV-2 Nucleocapsid Antibody (HC2003) conjugated Biotin and Streptavidin-HRP (M00091), are used as a secondary antibody (1 μg/mL, 0.2 μg/mL).

SARS-CoV-2 Nucleocapsid Protein

Lane 1: 1μg of SARS-CoV-2 Nucleocapsid protein, reducing(R)
Lane 2: 3μg of SARS-CoV-2 Nucleocapsid protein, reducing(R)
Lane 3: 5μg of SARS-CoV-2 Nucleocapsid protein, reducing(R)
Lane 4: 5μg of SARS-CoV-2 Nucleocapsid protein, non-reducing(NR)
> 90% as analyzed by SDS-PAGE

Species SARS-CoV-2
Protein Construction

N protein (Ser2-Ala419)
Accession # P0DTC9
Purity > 90% as analyzed by SDS-PAGE
Biological Activity SARS-CoV-2 Nucleocapsid protein can bind with SARS-CoV-2 Nucleocapsid Antibody (HC2003), Human Chimeric(Cat. No. A02039) in functional ELISA assay.
Expression System E. coli
Theoretical Molecular Weight 46 kDa
Formulation Supplied as a solution in PBS pH 7.4 containing 10% glycerol.
Concentration Please refer to the COA for the specific lot.
Storage & Stability Upon receiving, this product remains stable for up to 6 months at -20°C or below. Avoid repeated freeze-thaw cycles.

  • SARS-CoV-2 Nucleocapsid Protein
  • SARS-CoV-2 Nucleocapsid Protein

    Immobilized SARS-CoV-2 Nucleocapsid Antibody (HC2003), Human Chimeric (Cat. No. A02039) at 2 μg/mL can bind SARS-CoV-2 Nucleocapsid protein (Cat. No. Z03488) with a serial dilution.
    SARS-CoV-2 Nucleocapsid Antibody (HC2003) conjugated Biotin and Streptavidin-HRP (M00091), are used as a secondary antibody (1 μg/mL, 0.2 μg/mL).

  • SARS-CoV-2 Nucleocapsid Protein
  • SARS-CoV-2 Nucleocapsid Protein

    Lane 1: 1μg of SARS-CoV-2 Nucleocapsid protein, reducing(R)
    Lane 2: 3μg of SARS-CoV-2 Nucleocapsid protein, reducing(R)
    Lane 3: 5μg of SARS-CoV-2 Nucleocapsid protein, reducing(R)
    Lane 4: 5μg of SARS-CoV-2 Nucleocapsid protein, non-reducing(NR)
    > 90% as analyzed by SDS-PAGE


Target Background SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that causes illnesses ranging from the common cold to severe diseases. SARS-CoV-2 Nucleocapsid Protein is associated with nucleic acid. It is the most abundant protein for coronavirus. Because of the strong immunogenicity of coronavirus Nucleocapsid, it is believed that SARS-CoV-2 Nucleocapsid Protein has potential value for the diagnosis of the virus.
Synonyms Coronavirus NP; coronavirus Nucleocapsid; coronavirus Nucleoprotein; Novel coronavirus Nucleoprotein; 2019-nCoV N protein

For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.






For more documents, please visit "Technical Support".

Cat. No. Z03488
Size Price
100 μg $380.00
1 mg $2100.00